Literature DB >> 8138876

Controlled release of anticancer drug methotrexate from biodegradable gelatin microspheres.

R Narayani1, K P Rao.   

Abstract

Biodegradable hydrophilic gelatin microspheres containing the anticancer drug methotrexate (MTX) of different mean particle sizes (1-5, 5-10, and 15-20 microns) were prepared by polymer dispersion technique and crosslinked with glutaraldehyde. The microspheres were uniform, smooth, solid and in the form of free-flowing powder. About 80 per cent of MTX was incorporated in gelatin microspheres of different sizes. The in vitro release of MTX was investigated in two different media, namely simulated gastric and intestinal fluids. The release profiles indicated that gelatin microspheres released MTX in a zero-order fashion for 4-6 days in simulated gastric fluid and for 5-8 days in simulated intestinal fluid. The rate of release of MTX decreased with increase in the particle size of the microspheres. MTX release was faster in gastric fluid when compared to intestinal fluid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8138876     DOI: 10.3109/02652049409040439

Source DB:  PubMed          Journal:  J Microencapsul        ISSN: 0265-2048            Impact factor:   3.142


  6 in total

1.  Biodegradable drug delivery system for the treatment of bone infection and repair.

Authors:  L Di Silvio; W Bonfield
Journal:  J Mater Sci Mater Med       Date:  1999 Oct-Nov       Impact factor: 3.896

2.  Sustained release of methotrexate through liquid-crystalline folate nanoparticles.

Authors:  Rahul Misra; Sanat Mohanty
Journal:  J Mater Sci Mater Med       Date:  2014-06-22       Impact factor: 3.896

3.  Carbodiimide induced cross-linking, ligand addition, and degradation in gelatin.

Authors:  Christopher R Cammarata; Mitchell E Hughes; Clyde M Ofner
Journal:  Mol Pharm       Date:  2015-02-06       Impact factor: 4.939

4.  Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotrexate.

Authors:  Maria Grazia Cascone; Luigi Lazzeri; Claudia Carmignani; Zhouhai Zhu
Journal:  J Mater Sci Mater Med       Date:  2002-05       Impact factor: 3.896

Review 5.  Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers.

Authors:  Przemysław Koźmiński; Paweł Krzysztof Halik; Raphael Chesori; Ewa Gniazdowska
Journal:  Int J Mol Sci       Date:  2020-05-14       Impact factor: 5.923

6.  Evaluation of gum mastic (Pistacia lentiscus) as a microencapsulating and matrix forming material for sustained drug release.

Authors:  Dinesh M Morkhade
Journal:  Asian J Pharm Sci       Date:  2017-05-10       Impact factor: 6.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.